Influence of Nonpolio Enteroviruses and the Bacterial Gut Microbiota on Oral Poliovirus Vaccine Response: A Study from South India by Praharaj, Ira et al.
Ac
ce
pte
d M
an
us
cri
pt
 
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases 
Society of America. All rights reserved. For permissions, e-mail: 
journals.permissions@oup.com. 
Influence of non-polio enteroviruses and the bacterial gut microbiota on oral poliovirus 
vaccine response: a study from south India 
Ira Praharaj
1¶
*, Edward PK Parker
2¶
, Sidhartha Giri
1
, David J Allen
3,4
, Sophia Silas
1
, Revathi 
R
1
, Saravanakumar Puthupalayam Kaliappan
1
, Jacob John
5
, Jasmine Helan Prasad
5
, Beate 
Kampmann
6
, Miren Iturriza-Gómara
7
, Nicholas C Grassly
2&
, Gagandeep Kang
1& 
1
Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu 
632004, India  
2
Department of Infectious Disease Epidemiology, Imperial College London, London W2 
1PG UK 
3
Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, 
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK  
4
Enteric Virus Unit, Virus Reference Department, Microbiology Services, Public Health 
England, London NW9 5EQ, UK 
5
Department of Community Health, Christian Medical College, Vellore, Tamil Nadu, 
632004, India 
6
Department of Paediatrics, St Mary’s Campus, Imperial College London, London, UK 
7
Centre for Global Vaccine Research, Institute of Infection and Global Health, and NIHR 
Health Protection Research Unit in Gastrointestinal Infection, University of Liverpool, 
Liverpool L69 7BE UK 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy568/5106276 by U
niversity of Liverpool user on 28 Septem
ber 2018
Ac
ce
pte
d M
an
us
cri
pt
 
2 
 
* Correspondence to: Ira Praharaj, Christian Medical College, Vellore, Tamil Nadu, India; 
irapraharaj@cmcvellore.ac.in, Phone- +919751442591 
¶ Joint first authors. 
 
&
 Joint senior authors. 
Brief summary: Non-polio enteroviruses have a significant impact on oral poliovirus 
vaccine sero-response irrespective of infecting serotype, while the bacterial gut 
microbiota does not affect OPV sero-response significantly. 
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Abstract 
Background: Oral poliovirus vaccine (OPV) is less immunogenic in LMIC countries. We 
tested whether bacterial and viral components of the intestinal microbiota are associated with 
this phenomenon.  
Methods: We assessed prevalence of enteropathogens using TaqMan array cards 14 days 
before and at vaccination in 704 Indian infants (6-11 months) receiving monovalent type3 
OPV  (CTRI/2014/05/004588). Non-polio enterovirus (NPEV) serotypes were identified by 
VP1 sequencing. In 120 infants, pre-vaccination bacterial microbiota was characterised by 
16S rRNA sequencing.  
Results: We detected 56 NPEV serotypes on the day of vaccination. Concurrent NPEVs 
were associated with a reduction in OPV seroconversion, consistent across species (odds 
ratios and 95% CIs of 0·57[0·36–0·90], 0·61[0·43–0·86], and 0·69[0·41–1·16] for species A, 
B, and C, respectively). Recently acquired enterovirus infections,detected at vaccination, but 
not 14 days earlier had greater interfering effect on mOPV3 sero-response compared to 
persistent infections,with enterovirus detected at both time points (44/127[35%] vs 
63/129[49%] seroconversion,p=0.021). Abundance of specific bacterial taxa did not differ 
significantly according to OPV response, although microbiota diversity was higher in non-
responders at the time of vaccination. 
Conclusion: Enteric viruses have greater impact on OPV response than the bacterial 
microbiota with recent enterovirus infections having greater inhibitory effect than persistent 
infections. 
Key words: Non-polio enteroviruses, bacterial microbiota, 16S rRNA, OPV, next generation 
sequencing  
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Background  
Oral vaccines have consistently proven to be less immunogenic in low- and middle-income 
countries (LMICs) than high-income countries[1-3]. Several mechanisms may contribute to 
this phenomenon, including maternal factors (e.g. transplacental antibodies), heritable factors 
(e.g. genes determining histo-blood group antigen structure), and environmental factors (e.g. 
enteric pathogen exposure) [4]. The presence of asymptomatic enteric viruses – particularly 
non-polio enteroviruses (NPEVs) – has consistently been linked with a reduction in the 
immunogenicity of oral poliovirus vaccine (OPV)[5], potentially reflecting competition 
between viruses at the cellular level[6], activation of innate antiviral immune pathways that 
inhibit OPV replication, or changes in lymphocyte responsiveness to poliovirus antigen. 
Notably, more than 100 enterovirus serotypes are known to infect humans. These can be 
separated into four distinct species (A–D) based on the sequence of the VP1 gene (one of the 
major determinants of antigenicity), of which polioviruses fall within species C[7;8]. 
However, the relative inhibitory effect of different NPEV species or serotypes has not been 
investigated in any detail. 
Other components of the gut microbiota may also be pertinent to OPV outcome. Enteric 
viruses appear to exploit signals from the bacterial microbiota when colonising the intestinal 
mucosa[9]. Among infants in Bangladesh, Bifidobacterium abundance at the time of OPV 
administration correlated with poliovirus-specific IgG and CD4+ T-cell responses[10]. 
However, the potential influence of microbiota composition on OPV replication and 
neutralising antibody levels remains uncertain. 
During a recent clinical trial in India, the presence of enteric viruses (of which the majority 
were NPEVs) was associated with reduced seroconversion to monovalent type 3 OPV 
(mOPV3)[11]. Here, we report on a follow-up study in which we tested whether OPV 
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response was associated with specific enterovirus serotypes or species, short-term changes in 
enteric virus burden, or bacterial microbiota composition. 
Methods 
Study design 
Between 5 August 2014 and 21 March 2015, we carried out a randomised, placebo-controlled 
trial evaluating the effect of azithromycin on the immunogenicity of mOPV3 among 6–11-
month-old Indian infants (CTRI/2014/05/004588). The protocol and primary outcomes of this 
study have been published[11]. Briefly, 754 infants lacking serum neutralising antibodies to 
type 3 poliovirus were randomised 1:1 to receive a 3-day course of oral azithromycin 
(administered once daily at a dose of 10 mg/kg) or placebo, starting 14 days before the 
administration of a single dose of mOPV3. The study was approved by the institutional 
review board of the Christian Medical College, Vellore, India, and good clinical practice 
guidelines were followed throughout. 
Laboratory testing and bioinformatics 
Enteropathogen detection. Stool samples were collected from all infants before treatment 
(day -14) and on the day of vaccination (day 0) and tested for the presence of 40 different 
enteric bacterial, viral, and eukaryotic targets using Taqman array cards (TACs), as 
previously described (figure 1A)[11]. A cycle threshold (Ct) value of 30 was used as a 
universal cut-off for pathogen detection. In all day 0 samples that were positive for 
enteroviruses in the TAC assay (targeting the 5’ UTR), we carried out a semi-nested PCR 
assay targeting the VP1 gene[12]. Sanger sequencing of the amplified products was 
performed on a 3730XL DNA Analyzer and enterovirus serotypes were assigned using the 
RIVM Enterovirus Genotyping Tool (version 1.0)[13].  
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7 
Characterisation of the bacterial microbiota. We assessed bacterial microbiota 
composition in 120 infants (60 per study arm) selected at random from the first 300 trial 
participants. Our laboratory and bioinformatic methods for microbiota assessment in this 
cohort have been published[14]. For each infant, we included samples collected before 
treatment (day -14) and before vaccination (day 0). We also assessed samples from 40 adults 
living with trial participants to provide community-specific mature microbiota profiles (used 
as a reference for calculating microbiota age). Following amplification and sequencing of the 
16S rRNA gene V4 region via Illumina MiSeq, reads were assembled with FLASH, clustered 
de novo into operational taxonomic units (OTUs) using uclust (implemented in MacQIIME 
version 1.8.0), and taxonomically assigned using the RDP classifier.  
OPV outcome. Serum samples collected 21 days after mOPV3 administration were tested for 
neutralising antibodies against type 3 poliovirus using a modified microneutralization assay 
with two-fold serial dilutions ranging from 1:4 to 1:512[15]. Seroconversion was defined as 
the detection of neutralising antibodies at a dilution of ≥1:8. In a subset of 300 infants, 
shedding of type 3 poliovirus was assessed in stool samples collected 7 days after vaccination 
using real-time PCR[16].  
Statistical analysis 
Enteropathogen burden. We included all per-protocol infants with available day 0 TAC 
data in the final analysis (n=704). The association between each enterovirus species and OPV 
response (seroconversion or shedding as categorical dependent variables) was assessed by 
logistic regression. Age and study arm were included as covariates to account for the 
potential confounding of these variables with viral infection status and OPV outcome. We 
fitted univariate models for each species in turn and multivariate models that included all 
three species. Separate models were fitted for individual serotypes present in at least 1% of 
infants. Fisher’s exact test was used to compare the prevalence of each enterovirus species by 
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study arm. To examine whether mixed infections had an additive effect on OPV 
immunogenicity, we assessed the effect of enterovirus species count (as a categorical 
variable) on the odds of seroconversion. For each species in turn, we also compared the 
likelihood of heterospecific co-infection (≥1 enterovirus of another species) in infected versus 
uninfected infants using Fisher’s exact test. 
To test whether the association between infection and OPV response varied across 
enterovirus species, we used the likelihood ratio test (LRT) to compare the fit of logistic 
regression models that only included presence or absence of any enterovirus with models that 
included enterovirus species as a categorical variable. Where multiple species were detected, 
infections were classified as ‘mixed’, whilst untypeable infections were classified as 
‘unassigned’. 
To examine whether changes in the burden of viral TAC targets (adenovirus, astrovirus, 
enterovirus, norovirus, rotavirus and sapovirus) in the 14 days preceding immunisation 
influenced OPV outcome, we classified viruses as absent (not detected on days -14 or 0), 
resolved (present on day -14, absent on day 0), recently acquired (absent on day -14, present 
on day 0), or persistent (present on days -14 and 0) – hereafter referred to as ‘infection 
subclasses’. The impact of infection subclasses on OPV response was assessed by logistic 
regression, with age and study arm included as covariates. Infection subclasses were included 
if they contained at least ten infants. We directly compared OPV outcome between infants 
with recently acquired versus persistent infections using Fisher’s exact test; if a significant 
discrepancy was observed, we assessed whether this was associated with a difference in 
pathogen abundance (based on TAC Ct value) using Wilcoxon’s rank sum test. Analyses 
were implemented in the programming language R[17], and associations with a p value of 
<0·05 were considered statistically significant.  
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy568/5106276 by U
niversity of Liverpool user on 28 Septem
ber 2018
Ac
ce
pte
d M
an
us
cri
pt
 
9 
Microbiota composition. Among per-protocol infants in the microbiota subset, we compared 
baseline health and demographic characteristics by seroconversion status using Wilcoxon’s 
rank sum test (for continuous variables) or Fisher’s exact test (for categorical variables). We 
obtained a minimum of 7,708 sequences per sample after bioinformatic processing. To 
standardise sequencing depth, analyses were performed using 7,500 sequences per sample. 
Microbiota measures of interest included alpha diversity, beta diversity, microbiota stability, 
microbiota age, and relative taxon abundance. These were compared according to OPV 
outcome using Wilcoxon’s rank sum test (for comparisons of taxon abundance), linear 
regression (for alpha diversity, microbiota stability, and microbiota age), or Adonis (for beta 
diversity), adjusting for infant age and study arm where possible. Adonis is a permutation-
based analysis of variance. To account for multiple comparisons, p values for relative 
abundance comparisons were adjusted by Benjamini–Hochberg false discovery rate (FDR) 
correction[18], applied separately at each taxonomic rank. The association between alpha 
diversity and enterovirus infection subclass was assessed via linear regression. We also used 
the machine-learning algorithm Random Forests to predict OPV outcome based on OTU 
relative abundances. For each model, we carried out 20 cycles of 10-fold cross-validation 
using the R package crossval, with 5,000 trees per forest. Out-of-bag error rates and variable 
importance scores (based on Gini impurity) were determined across each of the 200 iterations 
of cross-validation. Sensitivity analyses of alpha and beta diversity were carried out in which 
azithromycin recipients were excluded. 
Data availability. 16S rRNA sequences have been deposited in the European Nucleotide 
Archive (accession number PRJEB20773). An OTU table and relevant metadata have 
previously been published[14].
  
Role of the funding source  
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The funder had no role in the study design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding and senior authors had full access to all the data 
in the study and had final responsibility for the decision to submit for publication. 
Results 
NPEV burden 
Enteroviruses were present at the time of vaccination (day 0) in 107/367 (29%) infants who 
seroconverted and 149/337 (44%) infants who failed to seroconvert (odds ratio [OR] 0·49, 
95% CI 0·35–0·67). Based on partial sequencing of the VP1 gene, species-level assignments 
were made in 247 (96%) of the 256 enterovirus-positive samples and serotype-level 
assignments were made in 234 (91%). Overall, we detected 56 NPEV serotypes, of which 11 
were present in at least 1% of the study population (figure 1B). Enteroviruses of species A, B, 
and C were detected in 90 (13%), 184 (26%), and 65 (9%) infants, respectively. Viruses in 
species D were absent. The receipt of azithromycin did not significantly impact the 
prevalence of any enterovirus species (figure S1). Infection with multiple enterovirus species 
was common – 76/704 (11%) infants harboured two species, while 8/704 (1%) were infected 
with three (figure S2). Moreover, the detection of any one enterovirus species was a 
significant risk factor for the presence of another (Table 1). 
Association between NPEVs and OPV response 
A negative association between NPEV detection and seroconversion to OPV3 was observed 
for each enterovirus species (ORs of 0·59 [0·37–0·93], 0·62 [0·44–0·87], and 0·67 [0·40–
1·13] for species A, B, and C, respectively, after adjusting for age and study arm; figure 1C). 
Although this effect was significant only for species A and B, there was no evidence that the 
effect size differed significantly between species (LRT, p=0·192). ORs were generally 
consistent in a multivariate model that included all species (Table S1), and the presence of 
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11 
multiple species did not have an additive inhibitory effect on seroconversion (ORs of 0·45 
[0·31–0·65], 0·67 [0·41–1·09], and 0·43 [0·09–1·80] for infants infected with one, two, or 
three species, respectively). With the exception of echovirus 14, associations between 
individual serotypes and seroconversion were not significant (Table S2). Consistent with the 
data for seroconversion status, the association between concurrent NPEVs and post-
vaccination shedding did not vary significantly by species (LRT, p=0·218; Table S1). 
Recently acquired, persistent, and  resolved viruses 
To investigate the relationship between recent changes in viral infection status and OPV 
response, we classified viruses as recently acquired, persistent, and  resolved (Table 2). 
“Recently acquired” enteroviruses were the only infection subclass to be significantly 
associated with OPV response (OR 0·38 [0·25–0·59], p<0·001). Notably, the seroconversion 
rate was significantly lower among infants with recently acquired as opposed to persistent 
enteroviruses (44/127 [35%] vs 63/129 [49%]; Fisher’s test, p=0·023). The Ct values of 
persistent versus recently acquired enterovirus infections on day 0 did not differ significantly 
(27·0 ± 2·2 [mean ± standard deviation] vs 27·2 ± 2·1; Wilcoxon’s rank sum test, p=0·475), 
suggesting that the difference in immunogenicity between these groups was not driven by 
viral copy number. 
The odds of OPV shedding were reduced in infants with either recently acquired or persistent 
enteroviruses on day 0 (ORs of 0·55 [0·28–1·08] and 0·47 [0·25–0·91], respectively). In 
contrast to the immunogenicity data, shedding rates did not significantly differ between these 
groups (25/53 [47%] vs 25/58 [43%] for recently acquired vs persistent enteroviruses; 
Fisher’s test, p=1·000). No other viral infection subclasses were significantly associated with 
vaccine virus shedding (Table S3). 
Association between bacterial microbiota composition and OPV response 
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12 
Of the 120 infants included in the microbiota subset, 114 (95%) completed the study per 
protocol. The effects of azithromycin on microbiota composition in these infants, including a 
reduction in the abundance of Proteobacteria and Verrucomicrobia, have previously been 
reported[14]. Baseline health and socio-demographic characteristics were generally 
comparable between OPV responders and non-responders in the microbiota subset (Table 
S4), although failure to seroconvert was associated with a lower height-for-age Z score at 
enrolment (day -14) – a discrepancy not apparent in the trial population as a whole[11].  
We did not observe a strong correlation between composition of the bacterial microbiota at 
the time of vaccination (day 0) and OPV immunogenicity (Figure 2; Table 3). Unifrac 
distance from adults (an indicator of increased microbiota age) was lower in non-responders 
compared with responders (Table 3), while seroconversion status accounted for a significant 
but small proportion of variance among samples based on Unifrac distances (adonis, 
p=0·031, R
2
=0·013; Table 3; Figure 2C). We did not observe significant differences in OTU 
count, Shannon index, microbiota stability, or relative taxon abundances according to 
seroconversion status (Table 3; Figure 2B). Random Forest models based on OTU abundance 
data failed to accurately distinguish infants according to OPV outcome (figure 2D). 
Similar results were obtained when comparing individuals according to vaccine shedding 
status (Table 3). In contrast to the immunogenicity data, however, OTU count and Shannon 
index were significantly higher among non-shedders than shedders, and the class Clostridia 
was enriched in non-shedders (relative abundance, 11·6 ± 10·2% vs 5·6 ± 7·7%; Wilcoxon’s 
rank sum test, FDR-corrected p=0·044; Table S5). Neither OTU count nor Shannon index 
varied significantly according to enterovirus infection subclass (LRT, p values >0·05; Figure 
S3), suggesting that the observed discrepancies in alpha diversity according to OPV outcome 
were not related to NPEV infection.  
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13 
We observed no significant differences in microbiota composition according to OPV 
outcome in baseline (day -14) samples (Table S6). Moreover, the primary outcomes were 
largely unaffected when infants in the azithromycin arm were excluded (Table S6). 
 
Discussion 
The notion that concurrent enteroviruses may interfere with OPV immunogenicity dates back 
to the earliest trials of this vaccine[5]. Aside from a handful of relatively small association 
studies[19;20], however, the extent to which this effect varies among enterovirus species or 
serotypes has not been tested. In a large cohort of Indian infants who received a single dose 
of mOPV3, we observed a significant inhibitory effect of concurrent NPEVs on OPV 
response. Moreover, we found this effect to be consistent across enterovirus species and 
enhanced when infection with these viruses was recently acquired. 
This study is among the first to characterise NPEV burden in asymptomatic infants living in a 
LMIC. Our findings highlight not only the high prevalence of NPEVs in this setting (35%), 
but their considerable diversity. We observed a total of 56 different NPEV serotypes, of 
which Coxsackievirus A6 – one of the major serotypes implicated in clinical conditions such 
as hand-foot-and-mouth disease[21] – was the most common. Two or more enterovirus 
species were detected in 11% of infants, and the presence of any one species was associated 
with an increased likelihood of hetero-specific co-infection, suggesting that shared risk 
factors (e.g. poor sanitation and hygiene) prompt multiple NPEV exposures. Several previous 
studies have employed cell culture to characterise the burden of NPEVs among children 
presenting with acute flaccid paralysis. For example, NPEVs were documented in 15% of 
cases in West Africa[22] and 19% in south-western India[23]. The higher prevalence of 
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NPEVs reported here among asymptomatic infants may reflect the enhanced sensitivity of 
PCR- versus culture-based detection methods[24].  
Of the 56 NPEV serotypes observed in this population, 45 were present in <1% of infants, 
limiting our capacity to compare the effect of individual serotypes on OPV. The consistent 
species-level associations suggest that evolutionary (and antigenic) distance from poliovirus 
– a species C enterovirus – does not influence the outcomes of concurrent infection. 
Likewise, in cell culture, numerous NPEV serotypes have been shown to interfere with 
poliovirus replication[6]. Notably, enteroviruses exhibit long-term cycles in transmission that 
vary across serotypes – whereas some strains show regular annual peaks, others cause 
epidemics once every few years[25]. Our study was performed between August and  March – 
a period typically associated with reduced NPEV transmission across India[26]. It is possible 
that distinct serotype-specific effects on OPV will only be apparent in particular seasons or 
years. Crucially, our findings are consistent with reports of seasonal variation in OPV 
immunogenicity[26] and suggest that planning OPV campaigns at times of year when 
enterovirus transmission is low may improve vaccine response. 
By considering viral infection burden at multiple time points before vaccination, we observed 
a reduction in OPV immunogenicity in infants with newly acquired as opposed to persistent 
enterovirus infections. This finding should be interpreted with caution given its modest effect 
size and the fact that the discrepancy was absent when considering OPV shedding. 
Nonetheless, the possibility that recently acquired viruses may have an enhanced inhibitory 
effect on OPV response is plausible. Viral infections initiate a cascade of innate immune 
effectors that typically peak within several days of exposure[27]. Meanwhile, enteroviruses 
interfere with protein synthesis and secretion pathways to repress host interferon 
responses[28]. If the induction of innate antiviral immunity is responsible for the inhibitory 
effect of enteroviruses on OPV, the greater effect of recently acquired NPEVs compared to 
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15 
persistent infections could be due to the waning and/or repression of innate antiviral 
responses over time. 
Intestinal viruses other than enteroviruses may also interfere with OPV. During the primary 
analysis of this cohort, rotaviruses and adenoviruses were associated with a reduction in OPV 
immunogenicity[11]. The same trends were evident here; however, the statistical power of 
individual comparisons was reduced by the distinction between persistent and recently 
acquired infection subclasses. Despite the potential inhibitory effect of other viruses, the 
considerably higher prevalence of enteroviruses ensures that this genus is likely to account 
for a much greater fraction of OPV failure. 
In addition to the effect of intestinal viruses, dysbiosis of the bacterial microbiota has been 
proposed as a possible cause of impaired oral vaccine performance in LMICs[29;30]. 
Although lacking a consistent definition, dysbiosis has typically been linked with a reduction 
in microbiota diversity and a detectable shift (or ‘perturbation’) in overall composition[31]. 
In this study, microbiota diversity was negatively correlated with OPV shedding. Given the 
modest effect size of the observed discrepancies and the fact that several previous studies 
have observed no such correlation[10;32;33], it appears unlikely that increased microbiota 
diversity represents a significant risk factor for vaccine failure, although it may be a marker 
for exposure to enteric infections. Other discrepancies in microbiota composition with respect 
to OPV response were modest, as exemplified by the inability of Random Forests to 
accurately distinguish responders from non-responders based on OTU abundance data. Thus, 
non-responders did not exhibit any clear manifestations of microbiota dysbiosis. 
Several other studies have looked at the possible effect of the bacterial microbiota on oral 
vaccine outcome. Among infants in Bangladesh, OPV response was positively correlated 
with Bifidobacterium abundance[10]. In Ghana, oral rotavirus vaccine immunogenicity was 
associated with an increased abundance of Streptococcus bovis and decreased abundance of 
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16 
the phylum Bacteroidetes[32], although no such discrepancies were apparent during a 
rotavirus vaccine study in Vellore, India[33]. Here, we did not identify any OTUs or genera 
that were significantly associated with OPV response. Although abundance of the class 
Clostridia was negatively correlated with vaccine shedding, given that older infants were less 
likely to respond to OPV[11], the observed discrepancy likely reflects the confounding of 
Clostridia abundance with age[14]. Differences in infant age, vaccine, laboratory methods, 
trial setting, and immunogenicity measure may all have contributed to the discrepancies in 
findings among studies reporting on the association between bacterial microbiota 
composition and oral vaccine response. For now, reproducible signatures of oral vaccine 
failure within the bacterial microbiota remain elusive. 
Our study has several limitations. Biases in amplification efficiency may have undermined 
our characterisation of the bacterial microbiota[34], while a focus on relative rather than 
absolute taxon abundance (accounting for variation in total microbial load) may have 
obscured potentially relevant associations[14;35]. By applying a Ct cut-off of 30 for pathogen 
targets during the TAC assays, we may have failed to characterise the effect of enteric viruses 
present at low abundance. Finally, during our analysis of infection subclasses, it is possible 
that the replacement of one virus with another would be mistakenly categorised as a 
persistent infection as we did not determine enterovirus serotype in samples collected 14 days 
prior to the vaccination.  
In conclusion, we did not observe any signs of bacterial microbiota dysbiosis among infants 
in India who failed to respond to mOPV3. The presence of NPEVs was associated with a 
lower response to OPV that was consistent across enterovirus species, and recently acquired 
enteroviruses appeared to inhibit OPV immunogenicity more than persistent infections. 
Although these findings do not preclude a role for more entrenched risk factors of OPV 
failure, such as the chronic inflammation associated with environmental enteropathy, they 
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suggest that the likelihood of responding to OPV may fluctuate from week to week and are 
consistent with seasonal trends in OPV immunogenicity that may reflect the abundance of 
NPEVs.  
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Table 1. Co-occurrence of enterovirus species. 
Subset Prevalence of ≥1 
heterotypic EV 
 
EV-A positive 59/90 (65·6)    
EV-A negative 157/614 (25·6)  
EV-B positive 65/184 (35·3)  
EV-B negative 63/520 (12·1)  
EV-C positive 52/65 (80·0)  
EV-C negative 182/639 (28·5)  
 
Data are n/N (%). P values for all comparisons <0·0001 (Fisher’s exact test). EV, enterovirus. 
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Table 2. Association between viral infection subclasses and OPV3 seroconversion. 
Pathogen Infection status N 
Seropositive,   
n (%) OR (95% CI) p p 
Rec vs Pe
 
Adenovirus Absent 507 269 (53·1) 
   
 
Resolved 74 45 (60·8) 1·36 (0·83–2·27) 0·227 
 
 
Recently 
acquired 
88 40 (45·5) 0·73 (0·46–1·16) 0·187  
 
Persistent 35 13 (37·1) 0·53 (0·26–1·07) 0·083 0·427 
Astrovirus Absent 684 355 (51·9) 
   
 
Resolved 10 5 (50·0) 1·10 (0·30–4·05) 0·886 
 
 
Recently 
acquired 
10 7 (70·0) 2·30 (0·58–10·81) 0·235  
 
Persistent 0 - - - - 
Enterovirus Absent 313 178 (56·9) 
   
 
Resolved 135 82 (60·7) 1·24 (0·82–1·90) 0·304 
 
 
Recently 
acquired 
127 44 (34·6) 0·38 (0·25–0·59) <0·001  
 
Persistent 129 63 (48·8) 0·70 (0·46–1·06) 0·091 0·023 
Norovirus Absent 604 318 (52·6) 
   
 
Resolved 39 22 (56·4) 1·18 (0·61–2·32) 0·616  
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Recently 
acquired 
46 20 (43·5) 0·70 (0·38–1·28) 0·246 
 
 
Persistent 15 7 (46·7) 0·67 (0·23–1·89) 0·440 1·000 
Rotavirus Absent 685 362 (52·8) 
   
 
Resolved 6 2 (33·3) - - 
 
 
Recently 
acquired 
12 3 (25·0) 0·34 (0·07–1·16) 0·109 
 
 
Persistent 1 0 (0·0) - - - 
Sapovirus Absent 671 348 (51·9) 
   
 
Resolved 15 8 (53·3) 1·11 (0·39–3·23) 0·844 
 
 
Recently 
acquired 
16 9 (56·2) 1·30 (0·47–3·7) 0·615 
 
 
Persistent 2 2 (100·0) - - - 
Age and study arm were included as covariates in all logistic regression models. CI, confidence interval; Rec, 
Recently acquired; OR, odds ratio; Pe, persistent. 
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Table 3. Association between bacterial microbiota comparison at the time of vaccination (day 0) and oral poliovirus vaccine response. 
Comparison Description Test 
Age/arm as 
covariates 
Seroconversion Shedding 
Seropositive 
(n=62)
a
 
Seronegative 
(n=52) p 
Shedders  
(n=42) 
Non-shedders  
(n=33) p 
Alpha diversity Number of OTU LR yes 68·8 ± 14·1 73·4 ± 15·3 0·198 65·4 ± 14·5 72·0 ± 16·4 0·034 
 Shannon index LR yes 2·62 ± 0·47 2·82 ± 0·55 0·077 2·57 ± 0·50 2·84 ± 0·59 0·032 
Beta diversity Unifrac distances between samples adonis Yes R
2
=0·013 0·036 R
2
=0·025 0·007 
Microbiota age Mean Unifrac distance from samples 
collected from non-cohabiting adults 
LR Yes 0·833 ± 0·042  0·811 ± 0·050  0·013 0·838 ± 0·046  0·806 ± 0·052  0·001 
Microbiota stability Unifrac distance between  
day 0 and 14 
LR yes 0·470 ± 0·071  0·460 ± 0·085  0·699 0·476 ± 0·078 0·455 ± 0·088  0·196 
Taxon abundance Phylum-, class-, genus-, and OTU-level 
relative abundances 
WRS no
c
 No discrepancies with FDR p<0·15 Clostridia enriched in non-shedders
b
 
Other Cross-validation accuracy of  
Random Forests 
- no
c
 Median 54·5% (IQR 45·5–63·6%; baseline 
accuracy
d
: 54·5%) 
Median 62·5% (IQR 50·0–75·0%; 
baseline accuracy
d
: 56·0%) 
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Data are mean ± standard deviation unless otherwise stated. FDR, adjusted for false discovery rate; IQR, interquartile range; LR, linear regression; OTU, operational taxonomic unit; 
WRS, Wilcoxon rank sum. 
a 
 120 infants were included in the microbiota subset, of which 114 completed the study per protocol and were included in the final analyses.
 
b
 See table S5 for full results. 
c 
 Whilst age and study arm could be included as covariates when applying linear regression or adonis, it was not possible to adjust for these variables when applying the Wilcoxon 
rank sum test (a non-parametric test) or Random Forests. 
d 
Expected accuracy if all individuals are assigned to the majority class. 
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Figure legends 
Figure 1. Association between non-polio enteroviruses and seroconversion. (A)  Study design. (B) 
Enterovirus serotypes with a prevalence of at least 1%. The diameter of the circle at each branch tip is 
proportional to serotype prevalence. Phylogenetic relationships are as described by Oberste and 
colleagues.
7
 Branch lengths are not proportional to phylogenetic distance. (C) Enterovirus prevalence 
by seroconversion status. Error bars indicate 95% CIs. CV, coxsackievirus; E, echovirus; EV, 
enterovirus; mOPV3, monovalent type 3 oral poliovirus vaccine; NPEV, non-polio enterovirus; * 
p<0·01; † p<0·05. 
Figure 2. Association between microbiota composition and seroconversion. (A) OTU count and 
Shannon index (mean ± standard error). (B) Class-level composition of the bacterial microbiota. (C) 
Unweighted Unifrac distances between samples, visualised by principal coordinates analysis. Mean 
values for each principal coordinate are indicated by dotted lines. (D) Cross-validation accuracy of 
Random Forest models based on OTU abundance data (median and inter-quartile range). The baseline 
accuracy is the expected accuracy if all individuals are assigned to majority class. OTU, operational 
taxonomic unit; PC, principal coordinate; * p<0·05. 
 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiy568/5106276 by U
niversity of Liverpool user on 28 Septem
ber 2018
Ac
ce
pte
d M
an
us
cri
pt
 
29 
Figure 1 
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Figure 2 
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